𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The anti-tumour efficacy of human recombinant interleukin 2

✍ Scribed by J. Bubeník; M. Indrová

Publisher
Springer-Verlag
Year
1987
Tongue
English
Weight
339 KB
Volume
24
Category
Article
ISSN
0340-7004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

In vivo anti-tumour activity of recombin
In vivo anti-tumour activity of recombinant MVM parvoviral vectors carrying the human interleukin-2 cDNA
✍ Karim El Bakkouri; Charlotte Servais; Nathalie Clément; Siew Chiat Cheong; Jean- 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 153 KB

## Background The natural oncotropism and oncotoxicity of vectors derived from the autonomous parvovirus, minute virus of mice (prototype strain) [MVM(p)], combined with the immunotherapeutic properties of cytokine transgenes, make them interesting candidates for cancer gene therapy. ## Methods

Dissimilar anti-tumour reactions induced
Dissimilar anti-tumour reactions induced by tumour cells engineered with the interleukin-2 or interleukin-15 gene in nude mice
✍ Di Carlo, Emma; Meazza, Raffaella; Basso, Stefania; Rosso, Ombretta; Comes, Albe 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 330 KB

Interleukin (IL)-15 shares immuno-stimulatory properties with IL-2 and is a potent inducer of natural killer (NK) cell function. The major histocompatibility complex (MHC) class I-negative human small cell lung cancer (SCLC) cell line N592, engineered to express a modi®ed IL-15 cDNA (N592/IL-15), se